Cost Structure (Mylan / EpiPen)

Last Updated by Anonymous | Update This Page Flag this page Delete This Page

rating: 0+x

A weak cost structure means Mylan / EpiPen’s costs are high in comparison to their competitors… … "Cost Structure (Mylan / EpiPen)" will have a long-term negative impact on this entity, which subtracts from the entity's value.

Affected Investments